Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT03820063
What this trial is testing

Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study

Who this might be right for
Breast Cancer
Borstkanker Onderzoek Groep 462
Large-scale testing (Phase 3)Active Not RecruitingNCT01996267
What this trial is testing

Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2

Who this might be right for
Breast CancerHER2 Positive
The Netherlands Cancer Institute 437
Early research (Phase 1)Study completedNCT03620201
What this trial is testing

M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+11 more
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT02129556
What this trial is testing

Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer

Who this might be right for
Metastatic Breast Cancer
ETOP IBCSG Partners Foundation 58
Large-scale testing (Phase 3)Active Not RecruitingNCT04457596
What this trial is testing

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2 Positive Breast Carcinoma+4 more
Alliance for Clinical Trials in Oncology 1,056
Not applicableLooking for participantsNCT07542496
What this trial is testing

Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease

Who this might be right for
Breast CancerHer 2 Positive Breast Cancer
Société Algérienne de Formation et Recherche en Oncologie 1,000
Not applicableLooking for participantsNCT06708910
What this trial is testing

AI-based pCR Assessment/Prediction in HER2-Positive BC Using PET/MRI

Who this might be right for
HER2 Positive Breast Carcinoma
Heinrich-Heine University, Duesseldorf 460
Not applicableLooking for participantsNCT07095023
What this trial is testing

Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer

Who this might be right for
Breast Cancers
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 112
Large-scale testing (Phase 3)Study completedNCT00567190
What this trial is testing

Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Genentech, Inc. 808
Testing effectiveness (Phase 2)UnknownNCT05255523
What this trial is testing

Pyrotinib Plus Trastuzumab After First-line TH (P) Treatment With HER-2 Positive Breast Cancer

Who this might be right for
Advanced Breast Cancer
Fujian Medical University Union Hospital 60
Not applicableLooking for participantsNCT06754059
What this trial is testing

Pyrotinib Combined With Trastuzumab for Maintenance Therapy After First-line TH (P) Therapy for HER2+ABC

Who this might be right for
HER2-positive Breast Cancer
zhangjie 60
Large-scale testing (Phase 3)Looking for participantsNCT03418961
What this trial is testing

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Who this might be right for
CardiotoxicityHER2/Neu PositiveMetastatic Malignant Neoplasm in the Brain+2 more
SWOG Cancer Research Network 491
Early research (Phase 1)Looking for participantsNCT04332588
What this trial is testing

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

Who this might be right for
HER2-positive Breast Cancer
University of Alabama at Birmingham 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07217990
What this trial is testing

Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer
Ohio State University Comprehensive Cancer Center 84
Testing effectiveness (Phase 2)Looking for participantsNCT06832904
What this trial is testing

Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05)

Who this might be right for
HER2-positive Breast CancerNeoadjuvant TherapyPyrotinib
First Affiliated Hospital of Zhejiang University 33
Early research (Phase 1)Study completedNCT00470847
What this trial is testing

Lapatinib in Combination With Radiation Therapy in Patients With Brain Metastases From HER2-Positive Breast Cancer

Who this might be right for
Breast CancerBrain Metastases
Nancy Lin, MD 35
Large-scale testing (Phase 3)Active Not RecruitingNCT06968585
What this trial is testing

A166 Versus Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Unresectable or Metastatic Breast Cancer Previously Treated With Trastuzumab and Taxane Therapy

Who this might be right for
HER2-positive Breast Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 365
Not applicableLooking for participantsNCT06711055
What this trial is testing

Taxane Combined Targeted Therapy for Low-risk HER2 Positive and Lymph Node Negative Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Shu Wang 285
Not applicableUnknownNCT03908749
What this trial is testing

A Real-world Clinical Study of Pyrotinib Maleate Tablets in the Treatment of Breast Cancer Patients With Positive Her-2

Who this might be right for
HER2 Positive Breast Carcinoma
Anhui Provincial Hospital 300
Not applicableUnknownNCT05063643
What this trial is testing

Cardiotoxicity of Targeted Therapy for HER-2 Positive Breast Cancer Patients at High Altitude

Who this might be right for
HER2-positive Breast CancerTargeted TherapyCardiac Toxicity+1 more
Affiliated Hospital of Qinghai University 132
Next Page